相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Imaging glutamate in schizophrenia: review of findings and implications for drug discovery
E. M. P. Poels et al.
MOLECULAR PSYCHIATRY (2014)
Glutamate modulators as potential therapeutic drugs in schizophrenia and affective disorders
Kenji Hashimoto et al.
EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE (2013)
Partial support for ZNF804A genotype-dependent alterations in prefrontal connectivity
Frieder M. Paulus et al.
HUMAN BRAIN MAPPING (2013)
Glutamate in Schizophrenia: A Focused Review and Meta-Analysis of H-1-MRS Studies
Anouk Marsman et al.
SCHIZOPHRENIA BULLETIN (2013)
Glutamate Levels in the Associative Striatum Before and After 4 Weeks of Antipsychotic Treatment in First-Episode Psychosis A Longitudinal Proton Magnetic Resonance Spectroscopy Study
Camilo de la Fuente-Sandoval et al.
JAMA PSYCHIATRY (2013)
Elevated Prefrontal Cortex γ-Aminobutyric Acid and Glutamate-Glutamine Levels in Schizophrenia Measured In Vivo With Proton Magnetic Resonance Spectroscopy
Lawrence S. Kegeles et al.
ARCHIVES OF GENERAL PSYCHIATRY (2012)
Glycine reuptake inhibitor RG1678: A pharmacologic characterization of an investigational agent for the treatment of schizophrenia
Daniela Alberati et al.
NEUROPHARMACOLOGY (2012)
Gestational Methylazoxymethanol Acetate Administration Alters Proteomic and Metabolomic Markers of Hippocampal Glutamatergic Transmission
Daniel J. Lodge et al.
NEUROPSYCHOPHARMACOLOGY (2012)
From Revolution to Evolution: The Glutamate Hypothesis of Schizophrenia and its Implication for Treatment
Bita Moghaddam et al.
NEUROPSYCHOPHARMACOLOGY (2012)
Regional Decoupling of N-acetyl-aspartate and Glutamate in Schizophrenia
Nina V. Kraguljac et al.
NEUROPSYCHOPHARMACOLOGY (2012)
Anterior Cingulate Glutamate Levels Related to Clinical Status Following Treatment in First-Episode Schizophrenia
Alice Egerton et al.
NEUROPSYCHOPHARMACOLOGY (2012)
Quantitative Meta-Analysis on State and Trait Aspects of Auditory Verbal Hallucinations in Schizophrenia
Simone Kuehn et al.
SCHIZOPHRENIA BULLETIN (2012)
D-Cycloserine: An Evolving Role in Learning and Neuroplasticity in Schizophrenia
Donald C. Goff
SCHIZOPHRENIA BULLETIN (2012)
Has an Angel Shown the Way? Etiological and Therapeutic Implications of the PCP/NMDA Model of Schizophrenia
Daniel C. Javitt et al.
SCHIZOPHRENIA BULLETIN (2012)
Six-month treatment with atypical antipsychotic drugs decreased frontal-lobe levels of glutamate plus glutamine in early-stage first-episode schizophrenia
Naoki Goto et al.
NEUROPSYCHIATRIC DISEASE AND TREATMENT (2012)
Glutamate neurocircuitry: theoretical underpinnings in schizophrenia
Thomas L. Schwartz et al.
FRONTIERS IN PHARMACOLOGY (2012)
Cortical Activations During Auditory Verbal Hallucinations in Schizophrenia: A Coordinate-Based Meta-Analysis
Renaud Jardri et al.
AMERICAN JOURNAL OF PSYCHIATRY (2011)
Altered Cortical Network Dynamics A Potential Intermediate Phenotype for Schizophrenia and Association With ZNF804A
Roberta Rasetti et al.
ARCHIVES OF GENERAL PSYCHIATRY (2011)
Dopamine-Glutamate Interactions: A Neural Convergence Mechanism of Common Schizophrenia Risk Variants
Heike Tost et al.
BIOLOGICAL PSYCHIATRY (2011)
Interactive Effects of DAOA (G72) and Catechol-O-Methyltransferase on Neurophysiology in Prefrontal Cortex
Devon C. Nixon et al.
BIOLOGICAL PSYCHIATRY (2011)
Glutamate as a Marker of Cognitive Function in Schizophrenia: A Proton Spectroscopic Imaging Study at 4 Tesla
Juan R. Bustillo et al.
BIOLOGICAL PSYCHIATRY (2011)
Neuroimaging markers. Their role for differential diagnosis and therapeutic decisions in personalized psychiatry
O. Gruber
NERVENARZT (2011)
Cognitive Control Deficits in Schizophrenia: Mechanisms and Meaning
Tyler A. Lesh et al.
NEUROPSYCHOPHARMACOLOGY (2011)
Higher Levels of Glutamate in the Associative-Striatum of Subjects with Prodromal Symptoms of Schizophrenia and Patients with First-Episode Psychosis
Camilo de la Fuente-Sandoval et al.
NEUROPSYCHOPHARMACOLOGY (2011)
Research Domain Criteria (RDoC): Toward a New Classification Framework for Research on Mental Disorders
Thomas Insel et al.
AMERICAN JOURNAL OF PSYCHIATRY (2010)
Genetic Variation in CACNA1C Affects Brain Circuitries Related to Mental Illness
Kristin L. Bigos et al.
ARCHIVES OF GENERAL PSYCHIATRY (2010)
Brain Function in Carriers of a Genome-wide Supported Bipolar Disorder Variant
Susanne Erk et al.
ARCHIVES OF GENERAL PSYCHIATRY (2010)
Assessments of Function and Biochemistry of the Anterior Cingulate Cortex in Schizophrenia
Meredith A. Reid et al.
BIOLOGICAL PSYCHIATRY (2010)
A neural system for evaluating the behavioural relevance of salient events outside the current focus of attention
Oliver Gruber et al.
BRAIN RESEARCH (2010)
Strategies to Enhance N-Methyl-D-Aspartate Receptor-Mediated Neurotransmission in Schizophrenia, a Critical Review and Meta-Analysis
Guochuan E. Tsai et al.
CURRENT PHARMACEUTICAL DESIGN (2010)
Effect of second-generation antipsychotics on cognition: current issues and future challenges
S. Kristian Hill et al.
EXPERT REVIEW OF NEUROTHERAPEUTICS (2010)
A randomized, double-blind, placebo-controlled comparison study of sarcosine (N-methylglycine) and D-serine add-on treatment for schizophrenia
Hsien-Yuan Lane et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2010)
Rethinking Mental Illness
Thomas R. Insel et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2010)
Selective GlyT1 Inhibitors: Discovery of [4-(3-Fluoro-5-trifluoromethylpyridin-2-yl)piperazin-1-yl]-[5-methanesulfonyl-2-((S)-2,2,2-trifluoro-1-methylethoxy)phenyl]methanone (RG1678), a Promising Novel Medicine To Treat Schizophrenia
Emmanuel Pinard et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Disturbed functional connectivity within brain networks subserving domain-specific subcomponents of working memory in schizophrenia: Relation to performance and clinical symptoms
Ilona Henseler et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2010)
1H-MRS at 4 Tesla in minimally treated early schizophrenia
J. R. Bustillo et al.
MOLECULAR PSYCHIATRY (2010)
The CACNA1C risk variant for bipolar disorder influences limbic activity
M. Wessa et al.
MOLECULAR PSYCHIATRY (2010)
From maps to mechanisms through neuroimaging of schizophrenia
Andreas Meyer-Lindenberg
NATURE (2010)
The functional neuroanatomy of symptom dimensions in schizophrenia: A qualitative and quantitative review of a persistent question
Vina M. Goghari et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2010)
Glutamate Receptor Ion Channels: Structure, Regulation, and Function
Stephen F. Traynelis et al.
PHARMACOLOGICAL REVIEWS (2010)
Facial Emotion Processing in Schizophrenia: A Meta-analysis of Functional Neuroimaging Data
Huijie Li et al.
SCHIZOPHRENIA BULLETIN (2010)
High dose D-serine in the treatment of schizophrenia
Joshua T. Kantrowitz et al.
SCHIZOPHRENIA RESEARCH (2010)
Neural correlates of reward processing in schizophrenia - Relationship to apathy and depression
Joe J. Simon et al.
SCHIZOPHRENIA RESEARCH (2010)
Schizophrenia, Just the Facts 5. Treatment and prevention Past, present, and future
Rajiv Tandon et al.
SCHIZOPHRENIA RESEARCH (2010)
Evidence That Altered Amygdala Activity in Schizophrenia Is Related to Clinical State and Not Genetic Risk
Roberta Rasetti et al.
AMERICAN JOURNAL OF PSYCHIATRY (2009)
Meta-analysis of 41 Functional Neuroimaging Studies of Executive Function in Schizophrenia
Michael J. Minzenberg et al.
ARCHIVES OF GENERAL PSYCHIATRY (2009)
Endophenotypes: Bridging Genomic Complexity and Disorder Heterogeneity
Thomas R. Insel et al.
BIOLOGICAL PSYCHIATRY (2009)
Brain mechanisms associated with background monitoring of the environment for potentially significant sensory events
Oliver Gruber et al.
BRAIN AND COGNITION (2009)
Using the Stroop task to investigate the neural correlates of symptom change in schizophrenia
Lydia Krabbendam et al.
BRITISH JOURNAL OF PSYCHIATRY (2009)
A systematic fMRI investigation of the brain systems subserving different working memory components in schizophrenia
I. Henseler et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2009)
Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis
Stefan Leucht et al.
LANCET (2009)
Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression
Arun Sreekumar et al.
NATURE (2009)
From identification of neurofunctional systems to individualization of treatment for schizophrenic disorders
O. Gruber et al.
NERVENARZT (2009)
The Dopamine Hypothesis of Schizophrenia: Version III - The Final Common Pathway
Oliver D. Howes et al.
SCHIZOPHRENIA BULLETIN (2009)
Neural Mechanisms of a Genome-Wide Supported Psychosis Variant
Christine Esslinger et al.
SCIENCE (2009)
Premorbid IQ in schizophrenia: A meta-analytic review
Kristen A. Woodberry et al.
AMERICAN JOURNAL OF PSYCHIATRY (2008)
Abnormal Glutamatergic Neurotransmission and Neuronal-Glial Interactions in Acute Mania
Dost Oenguer et al.
BIOLOGICAL PSYCHIATRY (2008)
Identification of loci associated with schizophrenia by genome-wide association and follow-up
Michael C. O'Donovan et al.
NATURE GENETICS (2008)
Collaborative genome-wide association analysis supports a role for ANK3 and CACNA1C in bipolar disorder
Manuel A. R. Ferreira et al.
NATURE GENETICS (2008)
Once-weekly D-cycloserine effects on negative symptoms and cognition in schizophrenia: An exploratory study
Donald C. Goff et al.
SCHIZOPHRENIA RESEARCH (2008)
Learning potential on the WCST in schizophrenia is related to the neuronal integrity of the anterior cingulate cortex as measured by proton magnetic resonance spectroscopy
Patricia Ohrmann et al.
SCHIZOPHRENIA RESEARCH (2008)
Substantia nigra/ventral tegmental reward prediction error disruption in psychosis
G. K. Murray et al.
MOLECULAR PSYCHIATRY (2008)
Aberrant hippocampal activity underlies the dopamine dysregulation in an animal model of schizophrenia
Daniel J. Lodge et al.
JOURNAL OF NEUROSCIENCE (2007)
Longitudinal grey-matter and glutamatergic losses in first-episode schizophrenia
Jean Theberge et al.
BRITISH JOURNAL OF PSYCHIATRY (2007)
The Cognitive and Negative Symptoms in Schizophrenia, Trial (CONSIST): The efficacy of glutamatergic agents for negative symptoms and cognitive impairments
Robert W. Buchanan et al.
AMERICAN JOURNAL OF PSYCHIATRY (2007)
Evidence for neuronal dysfunction in the anterior cingulate of patients with schizophrenia: A proton magnetic resonance spectroscopy study at 3 T
Stephen J. Wood et al.
SCHIZOPHRENIA RESEARCH (2007)
Epistasis between catechol-O-methyltransferase and type II metabotropic glutamate receptor 3 genes on working memory brain function
Hao-Yang Tan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Evidence for statistical epistasis between catechol-O-methyltransferase (COMT) and polymorphisms in RGS4, G72 (DAOA), GRM3, and DISC1: influence on risk of schizophrenia
Kristin K. Nicodemus et al.
HUMAN GENETICS (2007)
Social brain dysfunctions in schizophrenia: A review of neuroimaging studies
Eric Brunet-Gouet et al.
PSYCHIATRY RESEARCH-NEUROIMAGING (2006)
Intermediate phenotypes and genetic mechanisms of psychiatric disorders
Andreas Meyer-Lindenberg et al.
NATURE REVIEWS NEUROSCIENCE (2006)
Impact of complex genetic variation in COMT on human brain function
A. Meyer-Lindenberg et al.
MOLECULAR PSYCHIATRY (2006)
Dysfunction of ventral striatal reward prediction in schizophrenia
G Juckel et al.
NEUROIMAGE (2006)
Pathophysiologically based treatment interventions in schizophrenia
David A. Lewis et al.
NATURE MEDICINE (2006)
Glutamatergic drugs for schizophrenia
H. J. Tuominen et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2006)
Episodic memory-related activation in schizophrenia: meta-analysis
AM Achim et al.
BRITISH JOURNAL OF PSYCHIATRY (2005)
Midbrain dopamine and prefrontal function in humans:: interaction and modulation by COMT genotype
A Meyer-Lindenberg et al.
NATURE NEUROSCIENCE (2005)
Regionally specific disturbance of dorsolateral prefrontal-hippocampal functional connectivity in schizophrenia
AS Meyer-Lindenberg et al.
ARCHIVES OF GENERAL PSYCHIATRY (2005)
D-serine efficacy as add-on pharmacotherapy to risperidone and olanzapine for treatment-refractory schizophrenia
U Heresco-Levy et al.
BIOLOGICAL PSYCHIATRY (2005)
Neural correlates of working memory deficits in schizophrenic patients. Ways to establish neurocognitive endophenotypes of psychiatric disorders
O Gruber et al.
RADIOLOGE (2005)
Symptoms versus neurocognitive test performance as predictors of psychosocial status in schizophrenia: A 1-and 4-year prospective study
MM Kurtz et al.
SCHIZOPHRENIA BULLETIN (2005)
Executive control emerging from dynamic interactions between brain systems mediating language, working memory and attentional processes
O Gruber et al.
ACTA PSYCHOLOGICA (2004)
Longitudinal studies of cognition and functional outcome in schizophrenia: implications for MATRICS
MF Green et al.
SCHIZOPHRENIA RESEARCH (2004)
Working memory deficit as a core neuropsychological dysfunction in schizophrenia
H Silver et al.
AMERICAN JOURNAL OF PSYCHIATRY (2003)
Neural correlates of rapid reversal learning in a simple model of human social interaction
ML Kringelbach et al.
NEUROIMAGE (2003)
Prefrontal cortex dysfunction mediates deficits in working memory and prepotent responding in schizophrenia
WM Perlstein et al.
BIOLOGICAL PSYCHIATRY (2003)
Beauty in a smile: the role of medial orbitofrontal cortex in facial attractiveness
J O'Doherty et al.
NEUROPSYCHOLOGIA (2003)
Glutamate and glutamine measured with 4.0 T proton MRS in never-treated patients with schizophrenia and healthy volunteers
J Théberge et al.
AMERICAN JOURNAL OF PSYCHIATRY (2002)
Neural economics and the biological substrates of valuation
PR Montague et al.
NEURON (2002)
A PET study of the pathophysiology of negative symptoms in schizophrenia
SG Potkin et al.
AMERICAN JOURNAL OF PSYCHIATRY (2002)
Relation of prefrontal cortex dysfunction to working memory and symptoms in schizophrenia
WM Perlstein et al.
AMERICAN JOURNAL OF PSYCHIATRY (2001)
Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia
MF Egan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Functional neuroanatomy of auditory working memory in schizophrenia: Relation to positive and negative symptoms
V Menon et al.
NEUROIMAGE (2001)
A separate disease within the syndrome of schizophrenia
B Kirkpatrick et al.
ARCHIVES OF GENERAL PSYCHIATRY (2001)
The functional anatomy of auditory hallucinations in schizophrenia
BR Lennox et al.
PSYCHIATRY RESEARCH-NEUROIMAGING (2000)
Physiological dysfunction of the dorsolateral prefrontal cortex in schizophrenia revisited
JH Callicott et al.
CEREBRAL CORTEX (2000)
Schizophrenic subjects show aberrant fMRI activation of dorsolateral prefrontal cortex and basal ganglia during working memory performance
DS Manoach et al.
BIOLOGICAL PSYCHIATRY (2000)
Neuropsychology of first-episode schizophrenia: Initial characterization and clinical correlates
RM Bilder et al.
AMERICAN JOURNAL OF PSYCHIATRY (2000)
Neurocognitive deficits and functional outcome in schizophrenia: Are we measuring the right stuff?
MF Green et al.
SCHIZOPHRENIA BULLETIN (2000)
分享论文
